Mental Health DailyResearch. Evidence. Perspective.Published research on atomoxetine.
Among people prescribed ADHD medication in 5 health systems, recorded self-harm was most common in the 3 months before their first prescription, not after it.1 Risk fell once treatment began…
Read articleA 2026 double-blind randomized controlled trial by Kappes et al. in Psychopharmacology found something the smart-drug users likely wouldn’t have predicted: a single 30 mg dose of methylpheni…
Read articleAn overwhelming majority of medications used to treat ADHD (attention-deficit/hyperactivity disorder) are classified as psychostimulants. Although psychostimulant drugs tend to have an immed…
Read articleStrattera (Atomoxetine) is a relatively well-known NRI (norepinephrine reuptake inhibitor) that is commonly used for the treatment of ADHD. Its mechanism of action involves inhibiting the re…
Read articleNorepinephrine Reuptake Inhibitors (NRIs) are drugs that function primarily by inhibiting the reuptake of the neurotransmitter norepinephrine (noradrenaline) and/or epinephrine (adrenaline).…
Read articleStrattera is an NRI or “norepinephrine reuptake inhibitor” meaning it prevents the reuptake of the neurotransmitter norepinephrine. This drug has been found clinically effective for treating…
Read articleStrattera (Atomoxetine) is a unique drug that was created to treat ADHD (attention-deficit hyperactivity disorder). Unlike common stimulants, it works by inhibiting the reuptake of the neuro…
Read article
